Skip to main content

Table 3 Survival analyses of cancer-specific survival for extremity liposarcoma patients

From: Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study

  Univariate analysis Multivariate analysis
P HR 95.0% CI P
Age
  < 65 Reference Reference    
 65–76 0.416 1.25 0.83–1.88 0.277
  > 76 < 0.001 3.26 2.19–4.85 < 0.001
Tumor size
  < 7.4 Reference Reference    
 7.4–12.4 0.036 2.42 1.43–4.10 0.001
  > 12.4 < 0.001 3.73 2.32–6.01 < 0.001
Race
 Black Reference     
 Other 0.609     
 White 0.668     
Sex
 Female Reference Reference   
 Male 0.001 1.42 1.01–2.00 0.047
Histological type
 Liposarcoma, NOS Reference     
 Liposarcoma, well differentiated < 0.001     
 Myxoid liposarcoma 0.668     
 Round cell liposarcoma < 0.001     
 Pleomorphic liposarcoma < 0.001     
 Mixed liposarcoma 0.024     
 Fibroblastic liposarcoma 0.966     
 Dedifferentiated liposarcoma 0.002     
AJCC
 I/II Reference     
 III/IV < 0.001     
T
 T1 Reference     
 T2 0.007     
N
 N0 Reference     
 N1 0.088     
M
 M0 Reference Reference   
 M1 < 0.001 5.83 3.37–10.09 < 0.001
Surgery
 No Reference Reference   
 Yes < 0.001 0.43 0.21–0.85 0.015
Radiotherapy
 No Reference     
 Yes < 0.001     
Chemotherapy
 No Reference     
 Yes < 0.001     
Primary site
 Lower extremity Reference     
 Upper extremity 0.768     
Grade
 I Reference Reference    
 II < 0.001 3.95 2.13–7.33 < 0.001
 III < 0.001 14.10 8.34–23.85 < 0.001
 IV < 0.001 19.02 11.41–31.71 < 0.001
  1. HR Hazard ratio, CI Confidence interval, AJCC American Joint Committee on Cancer